Immunomodulatory properties of hempseed oligopeptides in an LRRK2-associated Parkinson's disease animal model

被引：0
|
作者：
Torrecillas-Lopez, Maria [1 ,3 ]
Rivero-Pino, Fernando [1 ,3 ,5 ]
Trigo, Paula [2 ]
Toscano-Sanchez, Rocio [1 ]
Gonzalez-De la Rosa, Teresa [1 ,3 ]
Villanueva, Alvaro [4 ]
Millan-Linares, M. Carmen [4 ]
Montserrat-De la Paz, Sergio [1 ,3 ]
Claro-Cala, Carmen M. [2 ,3 ]
机构：
[1] Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Seville, Spain
[2] Department of Pharmacology, Pediatrics and Radiology, School of Medicine, Universidad de Sevilla, Av Sanchez Pizjuan s/n, Seville,41009, Spain
[3] Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC, Universidad de Sevilla, Seville,41013, Spain
[4] Department of Food and Health, Instituto de la Grasa (IG-CSIC), CUtrera Km 1, Campus Universitario Pablo de Olavide, Building 46, Seville,41013, Spain
[5] European Food Safety Authority, Nutrition and Food Innovation Unit, Novel Foods Team, Parma, Italy
来源：
Food and Function | 2024年 / 15卷 / 22期
关键词：
Brain - Medicinal chemistry - Neurodegenerative diseases - Peptides;
D O I：
10.1039/d4fo03167a
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11115 / 11128
相关论文
共 50 条
  • [41] Identification and functional characterization of genetic modifier of penetrance in G2019S LRRK2-associated Parkinson's disease through family whole genome sequencing
    Ohnmacht, J.
    Bobbili, D.
    May, P.
    Glaab, E.
    Kaye, J.
    Finkbeiner, S.
    Kruger, R.
    MOVEMENT DISORDERS, 2022, 37 : S582 - S582
  • [42] Common variants of LRRK2 are not associated with sporadic Parkinson's disease
    Biskup, S
    Mueller, JC
    Sharma, M
    Lichtner, P
    Zimprich, A
    Berg, D
    Wüllner, U
    Illig, T
    Meitinger, T
    Gasser, T
    ANNALS OF NEUROLOGY, 2005, 58 (06) : 905 - 908
  • [43] A variation in LRRK2 is associated with Parkinson's disease in Asian population
    Funayama, M.
    Li, Y.
    Yoshino, H.
    Imamich, Y.
    Tomiyama, H.
    Yamamoto, M.
    Murata, M.
    Toda, T.
    Hattori, N.
    Mizuno, Y.
    MOVEMENT DISORDERS, 2006, 21 : S414 - S414
  • [44] Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
    Ben Sassi, Samia
    Nabli, Fatma
    Hentati, Emna
    Nahdi, Houda
    Trabelsi, Meriam
    Ben Ayed, Hela
    Amouri, Rim
    Duda, John Eric
    Farrer, Matthew John
    Hentati, Faycal
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (03) : 243 - 246
  • [45] Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease
    Martinez, Bridget
    Peplow, Philip V.
    NEURAL REGENERATION RESEARCH, 2018, 13 (09) : 1493 - 1506
  • [46] Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease
    Bridget Martinez
    Philip V.Peplow
    Neural Regeneration Research, 2018, 13 (09) : 1493 - 1506
  • [47] Membrane remodeling properties of the Parkinson's disease protein LRRK2
    Wang, X.
    Wu, Y.
    Cai, S.
    Ge, J.
    Lin, S.
    De Camilli, P.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 215 - 215
  • [48] Membrane remodeling properties of the Parkinson's disease protein LRRK2
    Wang, Xinbo
    Espadas, Javier
    Wu, Yumei
    Cai, Shujun
    Ge, Jinghua
    Shao, Lin
    Roux, Aurelien
    De Camilli, Pietro
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (43)
  • [49] The structure of LRRK2 and the conformational changes that are associated with LRRK2 activation and Parkinson's disease pathogenesis
    Weng, Jui-Hung
    Auto, Philip
    Lu, Tsan-Wen
    Taylor, Susan
    FASEB JOURNAL, 2020, 34
  • [50] The Structure of LRRK2 and the Conformational Changes that are Associated with LRRK2 Activation and Parkinson's Disease Pathogenesis
    Weng, Jui-Hung
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 41A - 41A
12345